Manassas, VA, United States — ATCC, the world’s premier biological materials management and standards organization, today announced a Task Order award with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS). As part of this […]
Cytiva and BioCentriq, a New Jersey based cell and gene therapy contract development and manufacturing organization (CDMO,) have been awarded funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a public-private partnership whose mission is to accelerate biopharmaceutical innovation. Viral clearance is a key regulatory requirement for all biopharmaceutical processes but is a […]
HALIFAX, Nova Scotia – 3DBioFibR, a leading innovator in tissue engineering, announced today it is launching two new collagen fiber products, μCollaFibR™ (pronounced micro-CollaFibR™) and CollaFibR™ 3D scaffold. Made using 3D BioFibR’s proprietary and new dry-spinning technology to create collagen fibers at commercial scales, these off-the-shelf products offer significant advantages for tissue engineering and tissue […]
Chip-A1 allows researchers to effectively model complex 3D tissues, such as the tumor microenvironment and skin, with direct compound dosing capabilities. Boston, MA – Emulate, Inc., the leading provider of next-generation in vitro models, today announced the launch of the Emulate Chip-A1™ Accessible Chip through an early access program. This new Organ-Chip design expands on the original […]
Agreements with Vizgen, Resolve Biosciences, and Ultivue expand end-to-end, large-scale, deep molecular profiling and custom data analytics services offering LEUVEN, Belgium — OMAPiX, a leading provider of spatial omics services and custom data analytics, today announced strategic partnerships with Vizgen, Inc., Resolve Biosciences, and Ultivue, Inc. As part of the agreements, OMAPiX scientists will use […]
On June 22, Shimadzu Corporation commenced trial sales of its Gut Bacteria Co-Culture Device (hereinafter “the Device”). The Device creates the mimicked environment of the human gut that allows the co-culture*1 of intestinal epithelial cells and gut bacteria. The technologies used in the Device were developed through the joint research with Professor Takane Katayama of the […]
MINNEAPOLIS and TOLOCHENAZ, Switzerland — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Lunaphore, Inc. Bio-Techne anticipates the acquisition to close in the first quarter of its fiscal 2024. Founded in 2014 and headquartered in […]
Platform selected to accelerate precision fermentation workflows, to support more sustainable and cost-effective manufacturing for active ingredients in vitamins and bioactives Early results demonstrate significant savings in time and resources applicable across a wide range of synthetic biology applications Cambridge, UK, and Copenhagen, Denmark: Sphere Fluidics, a company developing single cell analysis systems underpinned by its […]
· Investment in new global headquarters forms part of ongoing growth plans · Bespoke lab and office space designed to foster innovation and collaboration with colleagues and customers Greater London, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced it will relocate its Greater London global […]
LEIDEN, the Netherlands — MIMETAS, a global leader in human disease modeling announces that it has expanded its ongoing partnership with Astellas, a global pharmaceutical company, to include automation and application support. “We are truly honored by the trust of the Astellas team in our capabilities,” says Paul Vulto, CEO of MIMETAS. “Astellas is a true innovation leader that […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
